Akorn Company Profile (NASDAQ:AKRX)

About Akorn

Akorn logoAkorn Inc., together with its subsidiaries, is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health. The Prescription Pharmaceuticals segment is engaged in manufacturing and marketing generic and branded prescription pharmaceuticals, including ophthalmics, injectables, oral liquids, otics, topical, inhalants and nasal sprays. The Consumer Health segment is engaged in manufacturing and marketing branded and private-label animal health and OTC products. The Company's Akorn Consumer Health division (ACH) markets a portfolio of OTC brands and various formulations of private-label OTC pharmaceutical products. Its OTC brand is TheraTears Therapy for Your Eyes, which is a family of therapeutic eye care products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: AKRX
  • CUSIP: 00972810
Key Metrics:
  • Previous Close: $21.58
  • 50 Day Moving Average: $20.85
  • 200 Day Moving Average: $23.91
  • 52-Week Range: $125,240,000.00 - $17.57
  • Trailing P/E Ratio: 14.40
  • Foreward P/E Ratio: 9.81
  • P/E Growth: 1.93
  • Market Cap: $2.67B
  • Outstanding Shares: 125,240,000
  • Beta: 1.12
Profitability:
  • Net Margins: 16.58%
  • Return on Equity: 38.59%
  • Return on Assets: 14.15%
Debt:
  • Debt-to-Equity Ratio: 1.00%
  • Current Ratio: 4.14%
  • Quick Ratio: 2.99%
Additional Links:
Companies Related to Akorn:

Analyst Ratings

Consensus Ratings for Akorn (NASDAQ:AKRX) (?)
Ratings Breakdown: 2 Sell Ratings, 7 Hold Ratings, 8 Buy Ratings
Consensus Rating:Hold (Score: 2.35)
Consensus Price Target: $29.70 (39.59% upside)

Analysts' Ratings History for Akorn (NASDAQ:AKRX)
Show:
DateFirmActionRatingPrice TargetDetails
1/31/2017Jefferies Group LLCInitiated CoverageBuy$24.00View Rating Details
12/29/2016GuggenheimReiterated RatingBuy$40.00View Rating Details
12/1/2016Goldman Sachs Group, Inc. (The)Initiated CoverageSell$20.00View Rating Details
11/7/2016Deutsche Bank AGUpgradeHold -> Buy$28.00View Rating Details
11/7/2016WallachBeth CapitalDowngradeBuy -> Hold$40.00 -> $22.00View Rating Details
11/7/2016Bank of America CorpDowngradeBuy -> Underperform$22.00View Rating Details
11/4/2016Royal Bank of CanadaDowngradeOutperform -> Sector Perform$37.00 -> $24.00View Rating Details
11/4/2016RBC Capital MarketsDowngradeOutperform -> Sector Perform$37.00 -> $24.00View Rating Details
9/15/2016Piper Jaffray CompaniesUpgradeNeutral -> Overweight$33.00 -> $34.00View Rating Details
8/5/2016J P Morgan Chase & CoSet Price TargetBuy$45.00View Rating Details
8/2/2016Raymond James Financial, Inc.DowngradeOutperform -> Market PerformView Rating Details
8/2/2016Citigroup Inc.DowngradeMarket Perform$33.80 -> $34.00View Rating Details
5/26/2016Leerink SwannReiterated RatingHoldView Rating Details
3/22/2016Craig HallumReiterated RatingBuyView Rating Details
3/23/2016Susquehanna Bancshares IncLower Price TargetNeutral$32.00 -> $30.00View Rating Details
3/23/2016William BlairReiterated RatingOutperform$58.00 -> $36.00View Rating Details
3/22/2016S&P Equity ResearchLower Price Target$25.98 -> $21.97View Rating Details
3/21/2016NomuraLower Price TargetBuy$46.00 -> $42.00View Rating Details
9/9/2015JMP SecuritiesInitiated CoverageMarket PerformView Rating Details
3/27/2015Avondale PartnersInitiated CoverageOutperform$56.00View Rating Details
2/27/2015Needham & Company LLCDowngradeBuy -> HoldView Rating Details
(Data available from 2/26/2015 forward)

Earnings

Earnings History for Akorn (NASDAQ:AKRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/1/2017ListenView Earnings Details
11/3/2016Q316$0.54$0.56$267.04 million$284.00 millionViewListenView Earnings Details
8/4/2016Q216$0.55$0.58$272.99 million$280.70 millionViewListenView Earnings Details
5/16/2016Q116$0.43$0.54$268.00 millionViewListenView Earnings Details
2/26/2015Q414$0.45$0.50$218.87 million$227.80 millionViewListenView Earnings Details
11/6/2014Q314$0.25$0.27$155.20 million$132.70 millionViewListenView Earnings Details
8/5/2014Q214$0.20$0.25$145.16 million$150.70 millionViewListenView Earnings Details
5/6/2014Q114$0.15$0.16$91.44 million$90.60 millionViewN/AView Earnings Details
3/3/2014Q413$0.14$0.14$83.37 million$85.00 millionViewN/AView Earnings Details
11/5/2013Q313$0.14$0.15$80.43 million$81.90 millionViewN/AView Earnings Details
8/6/2013Q2 2013$0.13$0.14$75.06 million$77.00 millionViewN/AView Earnings Details
5/7/2013Q1 2013$0.14$0.13$74.07 million$73.90 millionViewN/AView Earnings Details
2/26/2013Q4 2012$0.12$0.13$69.42 million$71.50 millionViewN/AView Earnings Details
11/6/2012Q312$0.13$0.12$69.59 million$69.60 millionViewN/AView Earnings Details
8/7/2012$0.12$0.12ViewN/AView Earnings Details
5/8/2012$0.12$0.13ViewN/AView Earnings Details
3/6/2012$0.09$0.11ViewN/AView Earnings Details
11/1/2011$0.06$0.13ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Akorn (NASDAQ:AKRX)
Current Year EPS Consensus Estimate: $2.24 EPS
Next Year EPS Consensus Estimate: $2.17 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.50$0.50$0.50
Q2 20162$0.47$0.53$0.50
Q3 20163$0.52$0.53$0.53
Q4 20163$0.51$0.55$0.54
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Akorn (NASDAQ:AKRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Akorn (NASDAQ:AKRX)
Insider Ownership Percentage: 28.30%
Institutional Ownership Percentage: 74.75%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/15/2016Kenneth AbramowitzDirectorSell2,691$30.44$81,914.04View SEC Filing  
6/14/2016Joseph BonaccorsiSVPSell6,500$29.84$193,960.00View SEC Filing  
6/10/2016Kenneth AbramowitzDirectorSell14,675$30.16$442,598.00View SEC Filing  
6/9/2016Bruce KutinskyCOOSell142,000$31.12$4,419,040.00View SEC Filing  
6/7/2016Ronald M JohnsonDirectorSell7,542$31.49$237,497.58View SEC Filing  
6/6/2016Kenneth AbramowitzDirectorSell10,900$31.37$341,933.00View SEC Filing  
6/3/2016Joseph BonaccorsiSVPSell90,250$31.23$2,818,507.50View SEC Filing  
6/2/2016Alan D WeinsteinDirectorSell50,000$30.93$1,546,500.00View SEC Filing  
4/21/2015Mark M SilverbergVPSell29,000$55.00$1,595,000.00View SEC Filing  
3/10/2015John N KapoorDirectorBuy19,000$44.26$840,940.00View SEC Filing  
3/3/2015Rajat RaiCEOBuy5,000$47.70$238,500.00View SEC Filing  
2/18/2015Joseph BonaccorsiInsiderSell40,827$47.33$1,932,341.91View SEC Filing  
2/10/2015Ronald M JohnsonDirectorSell17,173$46.44$797,514.12View SEC Filing  
1/26/2015Rajat RaiCEOSell873,985$41.89$36,611,231.65View SEC Filing  
1/12/2015Mark M SilverbergVPSell38,602$41.00$1,582,682.00View SEC Filing  
1/9/2015Ronald M JohnsonDirectorSell17,173$40.46$694,819.58View SEC Filing  
1/2/2015Ronald M JohnsonDirectorSell14,300$36.12$516,516.00View SEC Filing  
1/2/2015Timothy A DickCFOSell30,150$36.03$1,086,304.50View SEC Filing  
12/15/2014Brian TambiDirectorSell1,200$41.86$50,232.00View SEC Filing  
12/12/2014Adrienne L GravesDirectorSell9,557$41.09$392,697.13View SEC Filing  
12/11/2014John N KapoorDirectorSell50,000$41.19$2,059,500.00View SEC Filing  
12/9/2014John R SabatVPSell43,173$40.53$1,749,801.69View SEC Filing  
12/1/2014Timothy A DickCFOSell30,875$39.23$1,211,226.25View SEC Filing  
11/3/2014Timothy A DickCFOSell122,222$44.08$5,387,545.76View SEC Filing  
10/1/2014Timothy A DickCFOSell122,222$35.24$4,307,103.28View SEC Filing  
9/12/2014Brian TambiDirectorSell13,800$38.00$524,400.00View SEC Filing  
9/11/2014Joseph BonaccorsiInsiderSell116,800$37.89$4,425,552.00View SEC Filing  
9/8/2014Kenneth AbramowitzDirectorSell4,500$36.54$164,430.00View SEC Filing  
9/8/2014Rajat RaiCEOSell147,000$36.78$5,406,660.00View SEC Filing  
9/8/2014Timothy A DickCFOSell45,000$37.61$1,692,450.00View SEC Filing  
9/4/2014Alan D WeinsteinDirectorSell5,000$38.49$192,450.00View SEC Filing  
8/26/2014John N KapoorDirectorSell50,000$38.99$1,949,500.00View SEC Filing  
8/7/2014Rajat RaiCEOSell903,659$33.62$30,381,015.58View SEC Filing  
6/13/2014Brian TambiDirectorBuy1,000$27.62$27,620.00View SEC Filing  
5/16/2014Rajat RaiCEOBuy5,000$26.76$133,800.00View SEC Filing  
5/14/2014Kenneth AbramowitzDirectorSell2,557$26.79$68,502.03View SEC Filing  
12/9/2013Alan WeinsteinDirectorSell20,000$25.52$510,400.00View SEC Filing  
12/3/2013Kenneth AbramowitzDirectorSell5,000$25.35$126,750.00View SEC Filing  
12/12/2012Alan D WeinsteinDirectorBuy30,500$13.67$416,935.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Akorn (NASDAQ:AKRX)
DateHeadline
News IconAkorn, Inc. (NASDAQ:AKRX) Target Price At $27.9 - Transcript Daily (NASDAQ:AKRX)
transcriptdaily.com - February 25 at 3:23 PM
News IconAnalyst Advice And Earnings Insight: STORE Capital Corporation (STOR), Akorn, Inc. (AKRX) - Post Analyst (NASDAQ:AKRX)
postanalyst.com - February 25 at 3:23 PM
News IconLevels in View for Akorn, Inc. (NASDAQ:AKRX) - Providence Standard (NASDAQ:AKRX)
providencestandard.com - February 24 at 3:28 PM
News IconAnalysts Peeling Back The Layers on Akorn, Inc. (NASDAQ:AKRX): Consensus Take - Winfield Review (NASDAQ:AKRX)
winfieldreview.com - February 24 at 3:28 PM
News IconIs It Time to go for Stericycle, Inc. (SRCL), Akorn, Inc. (AKRX ... - StockNewsJournal (NASDAQ:AKRX)
www.stocknewsjournal.com - February 24 at 3:28 PM
News IconAnalysts Peer Into Their Crystal Balls For Akorn, Inc. (NASDAQ:AKRX): Where Is It headed? - Winfield Review (NASDAQ:AKRX)
winfieldreview.com - February 23 at 8:28 PM
News IconTrading by the Numbers: Stock Review for Akorn, Inc. (NASDAQ:AKRX) - Rives Journal (NASDAQ:AKRX)
rivesjournal.com - February 23 at 3:27 PM
News IconAkorn, Inc. (NASDAQ:AKRX) – Fast Growth Play with Potential Stock Upside - Winfield Review (NASDAQ:AKRX)
winfieldreview.com - February 23 at 3:27 PM
News IconFiscal Year Earnings Estimate on Akorn, Inc.(AKRX) - Money Flow Index & Trends (NASDAQ:AKRX)
www.moneyflowtrends.com - February 23 at 3:27 PM
News IconAnalyst Views On Top Movers In Recent Trade: Akorn, Inc. (AKRX), Intersil Corporation (ISIL) - Post Analyst (NASDAQ:AKRX)
postanalyst.com - February 22 at 8:29 PM
News IconWatching the Levels on Shares of Akorn, Inc. (NASDAQ:AKRX) - Searcy News (NASDAQ:AKRX)
searcysentinel.com - February 22 at 3:27 PM
News IconLooking at the Levels for Akorn, Inc. (NASDAQ:AKRX) - The Standard (NASDAQ:AKRX)
6milestandard.com - February 22 at 3:27 PM
News IconEarnings Clues on Akorn, Inc. (AKRX), Jacobs Engineering Group Inc. (JEC) Analyst's Predictions - StockNewsJournal (NASDAQ:AKRX)
www.stocknewsjournal.com - February 21 at 6:53 AM
News IconStock Price of Akorn, Inc. (AKRX) Increases 6.3% - Highland Mirror (NASDAQ:AKRX)
www.highlandmirror.com - February 21 at 6:53 AM
News IconEPS Forecast Of Akorn, Inc. (NASDAQ:AKRX) Set At $0.61 - Transcript Daily (NASDAQ:AKRX)
transcriptdaily.com - February 19 at 6:49 AM
News IconAkorn, Inc. (NASDAQ:AKRX) Projected to Achieve EPS Of $0.55 - Stock Observer (NASDAQ:AKRX)
www.thestockobserver.com - February 18 at 3:25 PM
News IconEquity Perception: Analyst's Indicator Review for BorgWarner Inc ... - The USA Commerce (NASDAQ:AKRX)
theusacommerce.com - February 18 at 3:25 PM
News IconIs The Sell-Side Predicting That Akorn, Inc. (NASDAQ:AKRX) Will Move Higher? - Winfield Review (NASDAQ:AKRX)
winfieldreview.com - February 16 at 3:29 PM
News IconAkorn, Inc. (NASDAQ:AKRX) Price Target At $27.9 - Transcript Daily (NASDAQ:AKRX)
transcriptdaily.com - February 16 at 3:29 PM
News IconAnalyst's Predictions on Patterson Companies, Inc. (PDCO), Akorn, Inc. (AKRX) - StockNewsJournal (NASDAQ:AKRX)
www.stocknewsjournal.com - February 16 at 3:29 PM
News IconAre Analysts Optimistic About Where Akorn, Inc. (NASDAQ:AKRX) is ... - Winfield Review (NASDAQ:AKRX)
winfieldreview.com - February 16 at 7:37 AM
istreetwire.com logoEquities Trend Analysis: Akorn, Inc. (AKRX), DexCom, Inc. (DXCM), Discovery Communications, Inc. (DISCK) - iStreetWire (NASDAQ:AKRX)
istreetwire.com - February 16 at 7:37 AM
News IconAnalyst's Indicator Review for Akorn, Inc. (AKRX), UDR, Inc. (UDR) - The USA Commerce (NASDAQ:AKRX)
www.theusacommerce.com - February 16 at 7:37 AM
News IconStock Update on Earnings & Estimates for Akorn, Inc. (NASDAQ:AKRX) - Aiken Advocate (NASDAQ:AKRX)
aikenadvocate.com - February 14 at 8:45 PM
News IconShare Tracker: Akorn, Inc. (NASDAQ:AKRX) - Midway Monitor (NASDAQ:AKRX)
midwaymonitor.com - February 14 at 3:43 PM
News IconWhy Investors remained confident on Pilgrim's Pride Corporation (PPC), Akorn, Inc. (AKRX)? - StockNewsJournal (NASDAQ:AKRX)
stocknewsjournal.com - February 14 at 3:43 PM
News IconWhat are Analyst's Indicators for Akorn, Inc. (AKRX), Equity Commonwealth (EQC) - The USA Commerce (NASDAQ:AKRX)
theusacommerce.com - February 13 at 3:54 PM
capitalcube.com logoAkorn, Inc. breached its 50 day moving average in a Bearish Manner : AKRX-US : February 13, 2017 (NASDAQ:AKRX)
www.capitalcube.com - February 13 at 3:54 PM
News IconAkorn, Inc. (NASDAQ:AKRX) Stock ABR At 2.08 - Stock Observer (NASDAQ:AKRX)
www.thestockobserver.com - February 12 at 3:26 PM
News IconPrice Target Of Akorn, Inc. (NASDAQ:AKRX)At $27.9 - Transcript Daily (NASDAQ:AKRX)
transcriptdaily.com - February 12 at 3:26 PM
News IconSADIF Analytics releases new summary due diligence report for Akorn Inc ($AKRX). (NASDAQ:AKRX)
reports.pr-inside.com - February 11 at 2:01 AM
News IconChart Review for Akorn, Inc. (NASDAQ:AKRX) - Baldwin Journal (NASDAQ:AKRX)
baldwinjournal.com - February 10 at 8:59 PM
News IconAkorn, Inc. (NASDAQ:AKRX) Projected EPS At $0.55 - Stock Observer (NASDAQ:AKRX)
www.thestockobserver.com - February 10 at 8:59 PM
News IconTraders Secrets on Pebblebrook Hotel Trust (PEB), Akorn, Inc. (AKRX) - StockNewsJournal (NASDAQ:AKRX)
stocknewsjournal.com - February 10 at 8:59 PM
istreetwire.com logoStocks in the Spotlight: Akorn, Inc. (AKRX), TCF Financial ... - iStreetWire (NASDAQ:AKRX)
istreetwire.com - February 10 at 3:56 PM
News IconStock Tracker: Trend Analysis on Akorn Inc. (AKRX) - Providence Standard (NASDAQ:AKRX)
providencestandard.com - February 9 at 8:30 PM
News IconEquity Sheet: Reviewing the Numbers for Akorn, Inc. (NASDAQ:AKRX) - Baldwin Journal (NASDAQ:AKRX)
baldwinjournal.com - February 8 at 8:39 PM
finance.yahoo.com logoAkorn to Report Fourth Quarter and Full Year 2016 Results (NASDAQ:AKRX)
finance.yahoo.com - February 6 at 3:31 PM
News IconBuy, Sell or Hold? Analysts Approach: DiamondRock Hospitality ... - The USA Commerce (NASDAQ:AKRX)
theusacommerce.com - February 5 at 3:27 PM
News IconWhat’s in Akorn, Inc. (AKRX) After Forming Bearish Double Bottom? (NASDAQ:AKRX)
randolphguide.com - February 4 at 8:30 PM
News IconBuy, Sell or Hold? Analysts Approach: DiamondRock Hospitality Company (DRH), Akorn, Inc. (AKRX)? - The USA Commerce (NASDAQ:AKRX)
www.theusacommerce.com - February 3 at 3:33 PM
News IconAkorn Inc (NASDAQ:AKRX): From Top to Bottom - StockNewsJournal (NASDAQ:AKRX)
stocknewsjournal.com - February 2 at 1:37 AM
News IconAkorn, Inc. (NASDAQ:AKRX): Analyst Rating Changes and PT Levels - Post Analyst (NASDAQ:AKRX)
postanalyst.com - February 1 at 3:33 PM
News IconEarnings Forecast Research on Akorn, Inc. (AKRX) - Highland Mirror (NASDAQ:AKRX)
www.highlandmirror.com - February 1 at 3:32 PM
News IconAkorn, Inc. (AKRX) stock coverage initiated with "Buy" in note to investors by Jefferies Group LLC - BNB Daily (blog) (NASDAQ:AKRX)
www.baseball-news-blog.com - January 31 at 3:37 PM
News IconTaking a Look at the Chart for Akorn, Inc. (AKRX) - The USA Commerce (NASDAQ:AKRX)
theusacommerce.com - January 31 at 3:37 PM
forbes.com logoOversold Conditions For Akorn (NASDAQ:AKRX)
www.forbes.com - January 30 at 5:26 PM
seekingalpha.com logoAkorn slumps 7% on FDA OK of new ephedrine competitor (NASDAQ:AKRX)
seekingalpha.com - January 30 at 4:26 PM
News IconKeeping Tabs on Levels for Akorn, Inc. (NASDAQ:AKRX) - The Tribune (NASDAQ:AKRX)
lakecitytribune.com - January 29 at 8:27 PM
News IconInvestor Update on Shares of Akorn Inc. (AKRX) - Sherwood Daily (NASDAQ:AKRX)
sherwooddaily.com - January 29 at 1:38 AM

Social

What is Akorn's stock symbol?

Akorn trades on the NASDAQ under the ticker symbol "AKRX."

Where is Akorn's stock going? Where will Akorn's stock price be in 2017?

17 equities research analysts have issued 12-month target prices for Akorn's stock. Their forecasts range from $20.00 to $45.00. On average, they expect Akorn's share price to reach $29.70 in the next twelve months.

When will Akorn announce their earnings?

Akorn is scheduled to release their next quarterly earnings announcement on Wednesday, March, 1st 2017.

Who owns Akorn stock?

Akorn's stock is owned by many different of retail and institutional investors. Top institutional investors include Paulson & CO. Inc. (6.94%), William Blair Investment Management LLC (3.32%), State Street Corp (2.39%), FMR LLC (1.85%), Janus Capital Management LLC (1.80%) and Fiera Capital Corp (0.95%). Company insiders that own Akorn stock include Alan D Weinstein, Bruce Kutinsky, John N Kapoor, Joseph Bonaccorsi, Kenneth Abramowitz, Mark M Silverberg, Rajat Rai and Ronald M Johnson.

Who sold Akorn stock? Who is selling Akorn stock?

Akorn's stock was sold by a variety of institutional investors in the last quarter, including Fiera Capital Corp, Folger Hill Asset Management LP, FMR LLC, Clough Capital Partners L P, State Street Corp, Oxford Asset Management, Allianz Asset Management AG and Loomis Sayles & Co. L P. Company insiders that have sold Akorn stock in the last year include Alan D Weinstein, Bruce Kutinsky, Joseph Bonaccorsi, Kenneth Abramowitz and Ronald M Johnson.

Who bought Akorn stock? Who is buying Akorn stock?

Akorn's stock was acquired by a variety of institutional investors in the last quarter, including Paulson & CO. Inc., William Blair Investment Management LLC, Russell Investments Group Ltd., Janus Capital Management LLC, Federated Investors Inc. PA, Dimensional Fund Advisors LP, Gabelli Funds LLC and Columbia Wanger Asset Management LLC. Company insiders that have bought Akorn stock in the last two years include John N Kapoor and Rajat Rai.

How do I buy Akorn stock?

Shares of Akorn can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Akorn stock cost?

One share of Akorn stock can currently be purchased for approximately $21.28.

Akorn (NASDAQ:AKRX) Chart for Sunday, February, 26, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Akorn (NASDAQ:AKRX)

Earnings History Chart

Earnings by Quarter for Akorn (NASDAQ:AKRX)

Dividend History Chart

Dividend Payments by Quarter for Akorn (NASDAQ:AKRX)

Last Updated on 2/26/2017 by MarketBeat.com Staff